{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:43:02Z","timestamp":1774449782128,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jdermsci.2007.09.012","type":"journal-article","created":{"date-parts":[[2007,12,13]],"date-time":"2007-12-13T15:57:43Z","timestamp":1197561463000},"page":"241-248","source":"Crossref","is-referenced-by-count":33,"title":["Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: A randomized, multicenter, investigator-blinded, controlled study"],"prefix":"10.1016","volume":"49","author":[{"given":"Makoto","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Loesche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2007.09.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1747.2004.t01-2-.x","article-title":"Regulation of human sebaceous glands","volume":"123","author":"Thiboutot","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jdermsci.2007.09.012_bib2","first-page":"4","article-title":"Physiopathology of acne vulgaris: recent data, new understanding of the treatments","volume":"14","author":"Pawin","year":"2004","journal-title":"Eur J Dermatol"},{"issue":"Suppl. 3","key":"10.1016\/j.jdermsci.2007.09.012_bib3","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1067\/S0190-9622(03)01154-X","article-title":"A review of the use of combination therapies for the treatment of acne vulgaris","volume":"49","author":"Leyden","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib4","unstructured":"Ikeda S, supervising editor. Arata J, Nishikawa T, Takigawa M, editors. Chapter 23, B.1. Acne vulgaris. Standard textbook of dermatology. 6th ed. Tokyo: Igakushoin; 2001. p. 270\u201372 [in Japanese]."},{"key":"10.1016\/j.jdermsci.2007.09.012_bib5","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2165\/00003495-200363150-00005","article-title":"Current concepts of the pathogenesis of acne: implications for drug treatment","volume":"63","author":"Gollnick","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0278-2391(98)90467-0","article-title":"Current concepts in the pathogenesis and treatment of acne","volume":"56","author":"Baur","year":"1998","journal-title":"J Oral Maxillofac Surg"},{"issue":"Suppl. 1","key":"10.1016\/j.jdermsci.2007.09.012_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne. A report from a global alliance to improve outcomes in acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017844","article-title":"Topical drug treatment in acne","volume":"196","author":"Gollnick","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003495-199753030-00010","article-title":"Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne","volume":"53","author":"Brogden","year":"1997","journal-title":"Drugs"},{"issue":"Suppl. 52","key":"10.1016\/j.jdermsci.2007.09.012_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.1998.1390s2003.x","article-title":"Pharmacology of adapalene","volume":"139","author":"Michel","year":"1998","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1016\/j.jdermsci.2007.09.012_bib11","first-page":"123","article-title":"Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene","volume":"16","author":"Vega","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib12","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/S0190-9622(97)70056-2","article-title":"Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and US multicenter trials","volume":"36","author":"Cunliffe","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00370719","article-title":"Human in vivo pharmacology of topical retinoids","volume":"287","author":"Griffiths","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0190-9622(96)90443-0","article-title":"A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial","volume":"34","author":"Shalita","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1365-2133.1998.1390s2026.x","article-title":"Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life","volume":"139","author":"Grosshans","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib16","first-page":"10","article-title":"Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris","volume":"68","author":"Thiboutot","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x","article-title":"A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials","volume":"139","author":"Cunliffe","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib18","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1067\/S0190-9622(03)01152-6","article-title":"Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study","volume":"49","author":"Wolf","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib19","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1067\/S0190-9622(03)01153-8","article-title":"Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle","volume":"49","author":"Cunliffe","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib20","first-page":"289","article-title":"Cumulative irritation potential of adapalene cream and gel, 0.1% compared to tazarotene cream, 0. 05% and 0. 1%","volume":"75","author":"Dosik","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib21","first-page":"76","article-title":"Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations","volume":"72","author":"Greenspan","year":"2003","journal-title":"Cutis"},{"issue":"Suppl. 3","key":"10.1016\/j.jdermsci.2007.09.012_bib22","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1067\/S0190-9622(03)01151-4","article-title":"Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents","volume":"49","author":"Brand","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2133.1998.1390s2017.x","article-title":"Adapalene 01% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference","volume":"139","author":"Dunlap","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib24","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S0190-9622(97)70052-5","article-title":"Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients","volume":"36","author":"Caron","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 4","key":"10.1016\/j.jdermsci.2007.09.012_bib25","first-page":"20","article-title":"Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris","volume":"68","author":"Egan","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib26","first-page":"1347","article-title":"An epidemiological study of acne vulgaris in Japan by questionnaire","volume":"111","author":"Hayashi","year":"2001","journal-title":"Jpn J Dermatol"},{"issue":"5","key":"10.1016\/j.jdermsci.2007.09.012_bib27","first-page":"494","article-title":"Adapalene Gel 0.1% \u2013 topical retinoid-like molecule \u2013 for the treatment of Japanese patients with acne vulgaris: a multicenter, randomized, investigator- blinded, dose-ranging study","volume":"6","author":"Kawashima","year":"2007","journal-title":"Skinresearch"},{"issue":"5","key":"10.1016\/j.jdermsci.2007.09.012_bib28","first-page":"504","article-title":"One-year efficacy and safety of adapalene gel 0.1% gel in Japanese patients with acne vulgaris","volume":"6","author":"Kawashima","year":"2007","journal-title":"Skinresearch"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1468-3083.2007.02190.x","article-title":"Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%","volume":"21","author":"Thielitz","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1\/2","key":"10.1016\/j.jdermsci.2007.09.012_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF01964720","article-title":"The in vivo and in vitro anti-inflammatory activity of CD271: a new retinoid-like modulator of cell differentiation","volume":"29","author":"Hensby","year":"1990","journal-title":"Agents Actions"},{"issue":"6","key":"10.1016\/j.jdermsci.2007.09.012_bib31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-0625.2007.00552.x","article-title":"In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions","volume":"16","author":"Tenaud","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2007.09.012_bib32","unstructured":"Berson DS. Topical retinoids in primary care practice. Medscape. Published online: July 2003. http:\/\/www.medscape.com\/viewprogram\/2575_pnt."},{"key":"10.1016\/j.jdermsci.2007.09.012_bib33","first-page":"55","article-title":"Adapalene gel 0.1%: effective and well-tolerated in the topical treatment of acne vulgaris in Chinese patients","author":"Zhu","year":"2001","journal-title":"Cutis"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181107003453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181107003453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T04:22:14Z","timestamp":1546402934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181107003453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0923181107003453"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2007.09.012","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}